DNA methylation and gene expression profiling in further RB1-proficient MYCN-amplified retinoblastomas will help to better characterize differences in molecular circuitry in RB1−/− and RB1-proficient MYCN-amplified retinoblastoma. The gene discussed is RB1; the disease is retinoblastoma.